DRDeepanshi Rana

Deepanshi Rana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Deepanshi Rana has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Avijit Mazumder

    Department of Pharmacology, Noida Institute of Engineering and Technology (Pharmacy Institute), Knowledge Park-II, Greater Noida, 201306 Uttar Pradesh, India

    1 shared publication
  • Saumya Das

    Department of Pharmacology, Noida Institute of Engineering and Technology (Pharmacy Institute), 19, KnowledgePark- II, Greater Noida, 201306 Uttar Pradesh, India

    1 shared publication

Latest Publications

  • Rapid-Acting Antidepressants: Targeting Neuroplasticity Beyond Monoamines

    by Saumya Das, Avijit Mazumder, Deepanshi Rana

    Depression remains a leading cause of morbidity worldwide, with conventional monoaminergic antidepressants such as SSRIs and SNRIs limited by delayed onset and high rates of treatment resistance. Novel approaches that modulate neuroplasticity, particularly NMDA receptor antagonists like ketamine, have demonstrated rapid efficacy in treatment-resistant depression. Ketamine relieves symptoms within hours by promoting glutamate release, AMPA receptor activation, BDNF–TrkB signaling, and mTOR pathway engagement, leading to synaptic remodeling. This review focuses on ketamine as an adjunct or alternative to monoaminergic therapies, highlighting mechanistic pathways of synaptic scaling and dendritic spine formation. Comparative insights into psychedelics, neurosteroids, and investigational NMDA modulators are also discussed, with emphasis on translational limitations, biomarker feasibility, and ethical challenges in digital therapeutics.